Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Diabetes Mellitus
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
50%
Vascular Disease
50%
Antithrombotic Therapy
50%
Fluorescent Dye
50%
Angiotensin Receptor Antagonist
50%
Cardiovascular Disease
50%
Acetylsalicylic Acid
50%
Neovascularization (Pathology)
50%
Metformin
50%
Medicine and Dentistry
Patient with Type 2 Diabetes
100%
Cell Count
22%
Diabetes Mellitus
22%
Peripheral Blood Mononuclear Cell
22%
Glycemic
11%
Angiotensin Receptor Antagonist
11%
Fluorescent Dye
11%
Cardiovascular Disease
11%
Pressure Control
11%
Vascular Disease
11%
Glycemic Control
11%
Antithrombotic Therapy
11%
Statin
11%
Lifestyle Modification
11%
Blood Pressure
11%
In Vitro
11%
Glycon
11%
Acetylsalicylic Acid
11%
Vascular Surgery
11%
Keyphrases
Multifactorial Treatment
100%
Endothelial Progenitor Cells
100%
Quadruple Therapy
22%
Control Therapy
11%
Therapy Modification
11%
Diabetic Macroangiopathy
11%
Diabetic Microangiopathy
11%
Neuroscience
Progenitor Cell
100%
Diabetes Mellitus
22%
Peripheral Blood Mononuclear Cell
22%
Statin
11%
Antithrombotic
11%
Aspirin
11%
Metformin
11%
Fluorescent Dye
11%
Vascular Disease
11%
In Vitro
11%
Biochemistry, Genetics and Molecular Biology
Cell Count
22%
Peripheral Blood Mononuclear Cell
22%
Blood Pressure
11%
Angiotensin Receptor
11%
Statin
11%
Neovascularization (Pathology)
11%
Cholesterol Blood Level
11%
Lipid
11%
Glycemic Control
11%
Immunology and Microbiology
Peripheral Blood Mononuclear Cell
22%
Cell Count
22%
Glycemic Control
11%
Cholesterol Blood Level
11%
Angiotensin
11%
Fluorescence Labeling
11%
Neovascularization (Pathology)
11%
Blood Pressure
11%